TICKETSWEST.COM, INC. – Trademark Portfolio

Entity Type: 03

TICKETSWEST.COM, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TICKETSWEST. The owner is based in SPOKANE, IL.

201 W. NORTH RIVER DR.

SPOKANE, IL 99201

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TICKETSWEST.COM, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does TICKETSWEST.COM, INC. have?

TICKETSWEST.COM, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does TICKETSWEST.COM, INC. file in?

TICKETSWEST.COM, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.

What are TICKETSWEST.COM, INC.'s most well-known trademarks?

TICKETSWEST.COM, INC.'s registered trademark portfolio includes well-known marks such as TICKETSWEST. These are among 1 currently registered trademark in the portfolio.

What is TICKETSWEST.COM, INC.'s trademark registration success rate?

TICKETSWEST.COM, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.